In the US, Sensipar (cinacalcet systemic) is a member of the drug class calcimimetics and is used to treat Hypercalcemia of Malignancy, Primary Hyperparathyroidism and Secondary Hyperparathyroidism.
Ingredient matches for Sensipar
Cinacalcet hydrochloride (a derivative of Cinacalcet) is reported as an ingredient of Sensipar in the following countries:
- New Zealand
- South Africa
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.